25 results
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
acumen, business leadership, and board experience will contribute to the Company’s growth and successful commercialization of CyPath® Lung.
Sandeep … million. We believe Dr. Platt’s scientific acumen, business leadership, and board experience will contribute to the Company’s growth and successful
POS AM
BIAF
BioAffinity Technologies Inc
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
. Platt’s scientific acumen, business leadership, and board experience will contribute to the Company’s growth and successful commercialization … by LabCorp for $575 million. We believe Dr. Platt’s scientific acumen, business leadership, and board experience will contribute to the Company’s
8-K
EX-10.1
74u1 gkbp
5 Dec 23
Departure of Directors or Certain Officers
8:45am
8-K
EX-99.1
8jagvtwh
5 Dec 23
Departure of Directors or Certain Officers
8:45am
8-K
ulq 0ebs6
5 Dec 23
Departure of Directors or Certain Officers
8:45am
8-K
onisvw mzw
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-10.4
0ml1m uq2
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
DRS
zugb0z
14 Aug 23
Draft registration statement
12:00am
8-K
EX-99.1
32qf3 8xi4wmlxdc
1 May 23
Departure of Directors or Certain Officers
3:04pm
DEF 14A
x0dztvwuxqwq8lv7k5m
1 May 23
Definitive proxy
2:55pm
PRE 14A
uu93adzz0o pzog
19 Apr 23
Preliminary proxy
9:56pm
8-K
EX-99.1
sac8r0i3mdtdlnehd742
31 Mar 23
Results of Operations and Financial Condition
7:12pm
8-K
EX-99.1
psgoi
15 Dec 22
Other Events
1:26pm
424B4
1xb9s7u l1
2 Sep 22
Prospectus supplement with pricing info
3:25pm